Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
ADVERTISEMENT FEATUREAdvertiser retains sole responsibility for the content of this article
Optimizing gene therapy for severe central nervous system diseases
Voyager Therapeutics is developing potentially life-changing gene therapies to treat advanced Parkinson’s disease and other serious neurological disorders with a significant unmet medical need.